ACH-SITAGLIPTIN recall in Canada: May exceed acceptable intake limit
In plain language
This recall involves ACH-SITAGLIPTIN tablets sold in Canada. It's being recalled because certain lots may contain an impurity above the acceptable limit. Consult your healthcare provider before stopping use and follow the return/repair steps in the official notice.
What to do
- Verify if your product is affected by checking the lot number.
- Consult your healthcare provider before discontinuing use.
- Contact Accord Healthcare Inc. if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
ACH-SITAGLIPTIN 25 MG Tablet
Model: DIN 02512475
Lot: P2206573
ACH-SITAGLIPTIN 50 MG Tablet
Model: DIN 02512483
Lot: P2206574
ACH-SITAGLIPTIN 100 MG Tablet
Model: DIN 02512491
Lot: P2206575, P2206981
Why this matters
May exceed acceptable intake limit for NTTP
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: P2206573, P2206574, P2206575, P2206981
- 3
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: DIN 02512475, DIN 02512483, DIN 02512491
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
May exceed acceptable intake limit for NTTP
What should consumers do?
Verify if your product is affected by checking the lot number. Consult your healthcare provider before discontinuing use. Contact Accord Healthcare Inc. if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. May exceed acceptable intake limit for NTTP
When was this product recalled?
This product was recalled on August 13, 2024.
Is the Accord Healthcare Inc. brand affected by this recall?
Yes, Accord Healthcare Inc. products are affected by this recall. This recall involves ACH-SITAGLIPTIN tablets sold in Canada. It's being recalled because certain lots may contain an impurity above the acceptable limit. Consult your healthcare provider before stopping use and follow the return/repair steps in the official notice.